Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription


2 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
1 Antivir Ther
4 HIV Med
9 J Acquir Immune Defic Syndr
3 J Virol
7 Lancet
10 Lancet HIV
2 Lancet Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 Nature
1 Neurology
2 Pediatr Infect Dis J
5 PLoS Med
16 PLoS One
2 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Science
1 Vaccine
2 Virology


  1. BISSON GP, Ramchandani R, Miyahara S, Mngqibisa R, et al
    Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.
    AIDS. 2017 Jul 24. doi: 10.1097/QAD.0000000000001606.
    >> Share

  2. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
    AIDS. 2017;31:1859-1866.
    >> Share

  3. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
    HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.
    AIDS. 2017;31:1885-1889.
    >> Share

    Assisted partner services for HIV: ready to go global.
    AIDS. 2017;31:1891-1893.
    >> Share

  5. MCCLELLAND A, French M, Mykhalovskiy E, Gagnon M, et al
    The harms of HIV criminalization: responding to the 'association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.
    AIDS. 2017;31:1899-1900.
    >> Share

    AIDS Res Hum Retroviruses

  6. JAN PM, Arora SK
    Innate Sensing of HIV-1 by Dendritic Cell-Specific ICAM-3 Grabbing Nonintegrin on Dendritic Cells: Degradation and Presentation Versus Transmission of Virus to T Cells Is Determined by Glycan Composition of Viral Envelope.
    AIDS Res Hum Retroviruses. 2017 Jul 27. doi: 10.1089/aid.2016.0290.
    >> Share

  7. SHAIKH N, Saxena V, Pandey S, Patil A, et al
    HECT Domain and RCC1-Like Domain-Containing Protein 5 (HERC-5) Gene Polymorphisms in HIV-1-Infected Individuals: A Study from India.
    AIDS Res Hum Retroviruses. 2017 Jul 24. doi: 10.1089/aid.2017.0108.
    >> Share

    Antimicrob Agents Chemother

  8. FORD SL, Sutton K, Lou Y, Zhang Z, et al
    Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00487.
    >> Share

    Antivir Ther

  9. YEOH HL, Cheng A, Palmer C, Crowe SM, et al
    Frailty in men living with HIV: a cross-sectional comparison of three frailty instruments.
    Antivir Ther. 2017 Jul 21. doi: 10.3851/IMP3185.
    >> Share


    HIV agenda must be prioritised to reduce deaths from AIDS in sub-Saharan Africa.
    BMJ. 2017;358:j3638.
    >> Share

    Number of new HIV infections is rising in Russia.
    BMJ. 2017;358:j3543.
    >> Share

    Child treated for HIV in infancy has been healthy for nine years.
    BMJ. 2017;358:j3587.
    >> Share

    PrEP on demand reduces HIV infections, study finds.
    BMJ. 2017;358:j3619.
    >> Share

    HIV Med

  14. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    HIV Med. 2017 Jul 25. doi: 10.1111/hiv.12536.
    >> Share

  15. SCHEPER H, van Holten N, Hovens J, de Boer M, et al
    Severe depression as a neuropsychiatric side effect induced by dolutegravir.
    HIV Med. 2017 Jul 26. doi: 10.1111/hiv.12538.
    >> Share

  16. ORKIN C, Llibre JM, Gallien S, Antinori A, et al
    Nucleoside reverse transcriptase inhibitor-reducing strategies in HIV treatment: assessing the evidence.
    HIV Med. 2017 Jul 24. doi: 10.1111/hiv.12534.
    >> Share

  17. GUARALDI G, Malagoli A, Theou O, Brothers TD, et al
    Correlates of frailty phenotype and frailty index and their associations with clinical outcomes.
    HIV Med. 2017 Jul 24. doi: 10.1111/hiv.12527.
    >> Share

    J Acquir Immune Defic Syndr

  18. KUNZWEILER CP, Bailey RC, Okall DO, Graham SM, et al
    Factors associated with prevalent HIV infection among Kenyan MSM: The Anza Mapema Study.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001512.
    >> Share

  19. SCHAFFER EM, Agot K, Thirumurthy H
    The Association between Intimate Partner Violence and Women's Distribution and Use of HIV Self-Tests with Male Partners: Evidence from a Cohort Study in Kenya.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001502.
    >> Share

  20. LODI S, Costagliola D, Sabin C, Amo JD, et al
    Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older.
    J Acquir Immune Defic Syndr. 2017 Jul 21. doi: 10.1097/QAI.0000000000001498.
    >> Share

  21. DAVEY DLJ, M Wall K, Kilembe W, Khu Naw H, et al
    HIV incidence and predictors of HIV acquisition from an outside partner in serodiscordant couples in Lusaka, Zambia, 1995-2012.
    J Acquir Immune Defic Syndr. 2017 Jul 4. doi: 10.1097/QAI.0000000000001494.
    >> Share

  22. HUSNIK MJ, Brown ER, Marzinke M, Livant E, et al
    Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001503.
    >> Share

  23. PITTALIS S, Orchi N, Carli G, Navarra A, et al
    HIV self-testing in Italy.
    J Acquir Immune Defic Syndr. 2017 Jul 24. doi: 10.1097/QAI.0000000000001507.
    >> Share

  24. BRAUNSTEIN SL, Robbins RS, Daskalakis DC
    Missed Opportunities: Adapting the HIV Care Continuum to Reduce HIV-related Deaths.
    J Acquir Immune Defic Syndr. 2017 Jul 26. doi: 10.1097/QAI.0000000000001509.
    >> Share

  25. GREER AE, Ou SS, Wilson E, Piwowar-Manning E, et al
    A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052.
    J Acquir Immune Defic Syndr. 2017 Jul 26. doi: 10.1097/QAI.0000000000001511.
    >> Share

  26. BENGTSON AM, Pence BW, Mollan KR, Edwards JK, et al
    The relationship between efavirenz as initial antiretroviral therapy and suicidal thoughts among HIV-infected adults in routine care.
    J Acquir Immune Defic Syndr. 2017 Jul 26. doi: 10.1097/QAI.0000000000001510.
    >> Share

    J Virol

  27. HRABER P, Rademeyer C, Williamson C, Seaman MS, et al
    Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
    J Virol. 2017 Jul 26. pii: JVI.00991-17. doi: 10.1128/JVI.00991.
    >> Share

  28. TERMINI JM, Church ES, Silver ZA, Haslam SM, et al
    HIV and SIV Maintain High Levels of Infectivity in the Complete Absence of Mucin Type O-Glycosylation.
    J Virol. 2017 Jul 26. pii: JVI.01228-17. doi: 10.1128/JVI.01228.
    >> Share

  29. SCHALLER T, Bulli L, Pollpeter D, Betancor G, et al
    Effects of the inner nuclear membrane proteins SUN1/UNC-84A and SUN2/UNC-84B on the early steps of HIV-1 infection.
    J Virol. 2017 Jul 26. pii: JVI.00463-17. doi: 10.1128/JVI.00463.
    >> Share


  30. HODSON N, Bewley S
    Nelly Mugo and the response to HIV: more than just PrEP advocacy.
    Lancet. 2017;390:358.
    >> Share

  31. MARGOLIS DA, Gonzalez-Garcia J, Stellbrink HJ, Eron JJ, et al
    Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31917.
    >> Share

  32. BOYD MA, Cooper DA
    Long-acting injectable ART: next revolution in HIV?
    Lancet. 2017 Jul 21. pii: S0140-6736(17)31962.
    >> Share

  33. GREEN A
    The HIV response in Ukraine: at a crossroads.
    Lancet. 2017;390:347-348.
    >> Share

    The global HIV/AIDS epidemic-progress and challenges.
    Lancet. 2017;390:333.
    >> Share

  35. GRANICH R, Williams B, Montaner J, Zuniga JM, et al
    90-90-90 and ending AIDS: necessary and feasible.
    Lancet. 2017;390:341-343.
    >> Share

  36. BEYRER C, Das P, Horton R, Ryan O, et al
    The International AIDS Society-Lancet Commission on the future of the HIV response and global health.
    Lancet. 2017;390:344-345.
    >> Share

    Lancet HIV

  37. HEFFRON R, McClelland RS, Balkus JE, Celum C, et al
    Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
    Lancet HIV. 2017 Jul 18. pii: S2352-3018(17)30110.
    >> Share

  38. ALIZADEH A, Morasae EK, Almasi-Hashiani A
    Methodological and statistical issues related to analysis of survival.
    Lancet HIV. 2017;4:e330.
    >> Share

  39. DARCIS G, Moutschen M
    The effect of treatment simplification on HIV reservoirs.
    Lancet HIV. 2017;4:e328-e329.
    >> Share

    Initiatives to fill the gaps in Africa's AIDS response.
    Lancet HIV. 2017;4:e321.
    >> Share

  41. MOLINA JM, Charreau I, Spire B, Cotte L, et al
    Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Lancet HIV. 2017 Jul 21. pii: S2352-3018(17)30089.
    >> Share

  42. TAN DH
    PrEP on demand or every day?
    Lancet HIV. 2017 Jul 21. pii: S2352-3018(17)30088.
    >> Share

  43. TRICKEY A, May MT, Sterne JA
    Methodological and statistical issues related to analysis of survival - Authors' reply.
    Lancet HIV. 2017;4:e330.
    >> Share

  44. COHN SE
    Women in HIV trials: improving adherence and outcomes.
    Lancet HIV. 2017 Jul 17. pii: S2352-3018(17)30107.
    >> Share

  45. ORRELL C, Hagins DP, Belonosova E, Porteiro N, et al
    Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-l
    Lancet HIV. 2017 Jul 17. pii: S2352-3018(17)30095.
    >> Share

  46. VAN DE WIJGERT J, McCormack S
    Vaginal dysbiosis and pre-exposure prophylaxis efficacy.
    Lancet HIV. 2017 Jul 18. pii: S2352-3018(17)30130.
    >> Share

    Lancet Infect Dis

  47. BURKI T
    Claims of a cure for HIV come under fire.
    Lancet Infect Dis. 2017;17:484-485.
    >> Share

  48. SALAM AP, Pozniak AL
    Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment.
    Lancet Infect Dis. 2017;17:882.
    >> Share

    MMWR Morb Mortal Wkly Rep

  49. Announcement: Monitoring Selected National HIV Prevention and Care Objectives.
    MMWR Morb Mortal Wkly Rep. 2017;66:794.
    >> Share


  50. HIV milestone, discrimination suit and China's AI plans.
    Nature. 2017;547:384-385.
    >> Share


  51. MOULIGNIER A, Lamirel C, Picard H, Lebrette MG, et al
    Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.
    Neurology. 2017 Jul 26. pii: 10.1212/WNL.0000000000004265.
    >> Share

    Pediatr Infect Dis J

  52. COKER M, El-Kamary S, Enwonwu C, Blattner W, et al
    Perinatal HIV Infection and Exposure and their Association with Dental Caries in Nigerian Children.
    Pediatr Infect Dis J. 2017 Jul 19. doi: 10.1097/INF.0000000000001702.
    >> Share

  53. HALL EW, Morris SB, Moore BK, Erasmus L, et al
    Treatment Outcomes of Children with HIV Infection and Drug-Resistant TB in Three Provinces in South Africa, 2005-2008.
    Pediatr Infect Dis J. 2017 Jul 19. doi: 10.1097/INF.0000000000001691.
    >> Share

    PLoS Med

  54. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    >> Share

  55. SIMMS V, Dauya E, Dakshina S, Bandason T, et al
    Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey.
    PLoS Med. 2017;14:e1002360.
    >> Share

  56. GENG EH, Havlir DV
    The science of rapid start-From the when to the how of antiretroviral initiation.
    PLoS Med. 2017;14:e1002358.
    >> Share

  57. LIGHTFOOT M, Dunbar M, Weiser SD
    Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough.
    PLoS Med. 2017;14:e1002361.
    >> Share

  58. KOENIG SP, Dorvil N, Devieux JG, Hedt-Gauthier BL, et al
    Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
    PLoS Med. 2017;14:e1002357.
    >> Share

    PLoS One

  59. LIN B, Sun X, Su S, Lv C, et al
    HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China.
    PLoS One. 2017;12:e0181997.
    >> Share

  60. EVANS D, Schnippel K, Govathson C, Sineke T, et al
    Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2017;12:e0181238.
    >> Share

  61. CANTRES-ROSARIO YM, Acevedo-Mariani FM, Perez-Laspiur J, Haskins WE, et al
    Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment.
    PLoS One. 2017;12:e0181779.
    >> Share

  62. SGAIER SK, Sharma S, Eletskaya M, Prasad R, et al
    Attitudes and decision-making about early-infant versus early-adolescent male circumcision: Demand-side insights for sustainable HIV prevention strategies in Zambia and Zimbabwe.
    PLoS One. 2017;12:e0181411.
    >> Share

  63. BARSKA K, Kwiatkowska W, Knysz B, Arczynska K, et al
    The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV.
    PLoS One. 2017;12:e0181533.
    >> Share

  64. SARMA H, Islam MA, Khan JR, Chowdhury KIA, et al
    Impact of teachers training on HIV/AIDS education program among secondary school students in Bangladesh: A cross-sectional survey.
    PLoS One. 2017;12:e0181627.
    >> Share

  65. CARBALLO-DIEGUEZ A, Balan IC, Brown W 3rd, Giguere R, et al
    High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women.
    PLoS One. 2017;12:e0181607.
    >> Share

  66. KO Y, Song J, Lee SY, Moon JW, et al
    Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?
    PLoS One. 2017;12:e0181798.
    >> Share

  67. FATTI G, Shaikh N, Jackson D, Goga A, et al
    Low HIV incidence in pregnant and postpartum women receiving a community-based combination HIV prevention intervention in a high HIV incidence setting in South Africa.
    PLoS One. 2017;12:e0181691.
    >> Share

  68. KWIZERA R, Akampurira A, Williams D, Boulware DR, et al
    Acridine orange fluorescent microscopy is more sensitive than India ink light microscopy in the rapid detection of cryptococcosis among CrAg positive HIV patients.
    PLoS One. 2017;12:e0182108.
    >> Share

  69. MCKENNEY J, Chen A, Hoover KW, Kelly J, et al
    Correction: Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men.
    PLoS One. 2017;12:e0182593.
    >> Share

  70. PAREDES R, Tzou PL, van Zyl G, Barrow G, et al
    Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.
    PLoS One. 2017;12:e0181357.
    >> Share

  71. DE ROSSI N, Dattner N, Cavassini M, Peters S, et al
    Patient and doctor perspectives on HIV screening in the emergency department: A prospective cross-sectional study.
    PLoS One. 2017;12:e0180389.
    >> Share

  72. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    >> Share

  73. SIGFRID L, Murphy G, Haldane V, Chuah FLH, et al
    Integrating cervical cancer with HIV healthcare services: A systematic review.
    PLoS One. 2017;12:e0181156.
    >> Share

  74. DEROSE KP, Payan DD, Fulcar MA, Terrero S, et al
    Factors contributing to food insecurity among women living with HIV in the Dominican Republic: A qualitative study.
    PLoS One. 2017;12:e0181568.
    >> Share

    PLoS Pathog

  75. SEBASTIAN NT, Zaikos TD, Terry V, Taschuk F, et al
    CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.
    PLoS Pathog. 2017;13:e1006509.
    >> Share

  76. MARTINS MA, Shin YC, Gonzalez-Nieto L, Domingues A, et al
    Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.
    PLoS Pathog. 2017;13:e1006529.
    >> Share

    Proc Natl Acad Sci U S A

  77. HWANG JK, Wang C, Du Z, Meyers RM, et al
    Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2017 Jul 26. pii: 201709203.
    >> Share


  78. DABIS F, Bekker LG
    We still need to beat HIV.
    Science. 2017 Jul 20. pii: eaao4197. doi: 10.1126/science.aao4197.
    >> Share


  79. PATEL DP, Treat JR, Castelo-Socio L
    Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30933.
    >> Share


  80. VANCOILLIE L, Hebberecht L, Dauwe K, Demecheleer E, et al
    Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus.
    Virology. 2017;510:185-193.
    >> Share

  81. SCHMITT K, Mohan Kumar D, Curlin J, Remling-Mulder L, et al
    Modeling the evolution of SIV sooty mangabey progenitor virus towards HIV-2 using humanized mice.
    Virology. 2017;510:175-184.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016